Injoys
Social
A short written take on each piece of content: what changed and why it matters. Skim the point first, then follow through to the full article only for what interests you. Every take is drawn from real content, so the link takes you straight to the material it is based on.
AI data centers are turning power into a strategy issue. One key takeaway: grid bottlenecks aren’t just about generation—they also involve transmission, substations, connection queues, and permitting. Read more : https://injoys.com/en/articles/ai-data-center-power-grid-tariffs-carbon #AI #Energy
A surprise deposit or “easy” transfer job can be a red flag. Learn how mule accounts are recruited—and why you should report unexpected deposits to your bank instead of sending money onward. https://injoys.com/en/articles/daepotongjang-voice-phishing-prevention #FraudPrevention
Checklist for the EU AI Act, Effective August 2026: Generative AI Labeling and GPAI Requirements
An EU-facing AI team prepares for August 2, 2026. This guide turns EU AI Act labeling, GPAI documentation, and systemic-risk duties into a practical review list. Read it before setting the compliance plan.
How to Maintain Kidney Health: Understanding Diet, Exercise, Dialysis, and Transplantation for Chronic Kidney Disease
Kidney disease can progress quietly. One key takeaway: don’t wait for symptoms—monitor eGFR and urine protein/albumin, especially if you have high blood pressure or diabetes. https://injoys.com/en/articles/kidney-health-ckd-diet-dialysis-transplant #KidneyHealth
Summary of the Government’s Three Major Mega-Projects: Semiconductors, Physical AI, and Data Centers
8.4 GW starts the AI data center plan. About ₩550 trillion is planned for phase 1, with 15 GW targeted long term. Read what those figures mean—and what still governs execution.
The Spread of Ebola in Bundibugyo and Clinical Trials of Antiviral Drugs: Key Issues in the 2026 Public Health Emergency
Case counts don’t tell the whole story in the 2026 Bundibugyo emergency. Risk also depends on transmission routes, healthcare capacity, worker protection, and whether clinical trials can produce usable evidence. Read more : https://injoys.com/en/articles/bundibugyo-ebola-2026-clinical-trials-pheic #GlobalHealth